Gender, age, and season at immunization uniquely influence the genetic control of susceptibility to histopathological lesions and clinical signs of experimental allergic encephalomyelitis: Implications for the genetics of multiple sclerosis

American Journal of Pathology

Volumn 165, Issue 5, 2004, Pages 1593-1602

  Teuscher, Cory ^a   Bunn, Janice Y ^b   Fillmore, Parley D ^c   Butterfield, Russell J ^c   Zachary, James F ^c   Blankenhorn, Elizabeth P ^d  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DETERMINATION; ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENDER; GENE LOCUS; GENETIC REGULATION; GENETICS; HISTOPATHOLOGY; IMMUNIZATION; INFECTION CONTROL; INFECTION SENSITIVITY; LINKAGE ANALYSIS; LOGISTIC REGRESSION ANALYSIS; MALE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RISK; SEASON; SEX RATIO; SPINAL CORD LESION; SPRING; STATISTICAL SIGNIFICANCE; SUMMER; WINTER;

EID: 7244261723     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63416-5     Document Type: Article

References (66)

1. Whitaker JN, Mitchell G: Clinical features of multiple sclerosis. Multiple Sclerosis: Clinical and Pathogenetic Basis. Edited by CS Raine, HF McFarland, WW Tourtellotte. London, Chapman and Hall, 1997, pp 3-20
2. Raine CS: Demyelinating diseases. Textbook of Neuropathology. Edited by RL Davis, DM Robertson. Baltimore, Williams and Wilkins, 1997, pp 627-715
3. Compston A, Coles A: Multiple sclerosis. Lancet 2002, 359:1221-1231
4. Lublin FD, Reingold SC: Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis, Neurology 1996, 46:907-911
5. Kurtzke JF: Epidemiological evidence for MS as an infection. Clin Microbiol Rev 1993, 6:382-427
6. Poskanzer D, Schapira K, Miller H: MS and poliomyelitis. Lancet 1963, 11:917-921
7. Kurtzke J, Hyllested K: Multiple sclerosis in the Faroe Islands. I. Clinical and epidemiological features. Ann Neurol 1979, 5:6-21
8. Normal J, Kurtzke J, Beebe G: Epidemiology of multiple sclerosis in U.S. veterans: 2. Latitude, climate and the risk of multiple sclerosis. J Chron Dis 1983, 36:551-559
9. Xu XX, McFarlin DE: Oligoclonal bands in CSF of twins with multiple sclerosis. Neurology 1984, 34:769-774
10. Herrera BM, Ebers GC: Progress in deciphering the genetics of multiple sclerosis. Curr Opin Neurol 2003, 16:253-258
11. Casetta I, Granieri E: Prognosis of multiple sclerosis: environmental factors. Neurol Sci 2000, 21:3839-3842
12. Ebers GC, Sadovnick AD: Epidemiology. Multiple sclerosis. Edited by DE Paty, GC Ebers. Philadelphia, FA Davis, 1998, pp 5-28
13. Ewing C, Bernard CC: Insights into the etiology and pathogenesis of multiple sclerosis. Immunol Cell Biol 1998, 76:47-54
14. Constantinescu CS, Milliard B, Fujioka T, Bhopale MK, Calida D, Rostami AM: Pathogenesis of neuroimmunologic diseases. Experimental models. Immunol Res 1998, 17:217-227
15. Butterfield RJ, Blankenhorn EP, Roper RJ, Zachary JF, Doerge RW, Sudweeks J, Rose J, Teuscher C: Genetic analysis of disease subtypes and sexual dimorphisms in mouse experimental allergic encephalomyelitis (EAE): relapsing/remitting and monophasic remitting/nonrelapsing EAE are immunogenetically distinct. J Immunol 1999, 162:3096-3102
16. Bettelli E, Pagany M, Weiner HL, Linington C, Sobel RA, Kuchroo VK: Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J Exp Med 2003, 197:1073-1081
17. Teuscher C, Mickey WF, Grafer CM, Tung KS: A common immunoregulatory locus controls susceptibility to actively induced experimental allergic encephalomyelitis and experimental allergic orchitis in BALB/c mice. J Immunol 1998, 160:2751-2756
18. Blankenhorn EP, Butterfield RJ, Rigby R, Cort L, Giambrone D, McDermott P, McEntee K, Solowski N, Meeker ND, Zachary JF, Doerge RW, Teuscher C: Genetic analysis of the influence of pertussis toxin on experimental allergic encephalomyelitis susceptibility: an environmental agent can override genetic checkpoints. J Immunol 2000, 164:3420-3425
19. Fillmore PD, Brace M, Troutman SA, Blankenhorn EP, Diehl S, Rincon M, Teuscher C: Genetic analysis of the influence of neuroantigen-complete Freund's adjuvant emulsion structures on the sexual dimorphism and susceptibility to experimental allergic encephalomyelitis. Am J Pathol 2003, 163:1623-1632
20. Butterfield RJ, Sudweeks JD, Blankenhorn EP, Korngold R, Marini JC, Todd JA, Roper RJ, Teuscher C: New genetic loci that control susceptibility and symptoms of experimental allergic encephalomyelitis in inbred mice. J Immunol 1998, 161:1860-1867
21. Butterfield RJ, Blankenhorn EP, Roper RJ, Zachary JF, Doerge RW, Teuscher C: Identification of genetic loci controlling the characteristics and severity of brain and spinal cord lesions in experimental allergic encephalomyelitis. Am J Pathol 2000, 157:637-645
22. Yule GU: Notes on the association of attributes in statistics. Biometrika 1903, 2:121-134
23. Simpson EH: The interpretation of interaction in contingency tables. J Roy Stat Soc 1951, 13:238-241
24. Clark AG: Limits to the prediction of phenotype from knowledge of genotype. Limits to Knowledge in Evolutionary Genetics. Edited by MT Clegg, M Hecht, RJ MacIntyre. New York, Kluwer Academic/Plenum Publishers, 2000, pp 205-224
25. Heydtmann M: The nature of truth: Simpson's paradox and the limits of statistical data. Q J Med 2002, 95:247-249
26. Kim S, Voskuhl RR: Decreased IL-12 production underlies the decreased ability of male lymph node cells to induce experimental autoimmune encephalomyelitis. J Immunol 1999, 162:5561-5568
27. Stohlman SA, Matsushima GK, Casteel N, Frelinger JA: The defect in delayed-type hypersensitivity of young adult SJL mice is due to a lack of functional antigen-presenting cells. Eur J Immunol 1985, 15:913-916
28. Cua DJ, Hinten DR, Kirkman L, Stohlman SA: Macrophages regulate induction of delayed-type hypersensitivity and experimental allergic encephalomyelitis in SJL mice. Eur J Immunol 1995, 25:2318-2324
29. Bebo Jr BF, Schuster JC, Vandenbark AA, Offner H: Androgens alter the cytokine profile and reduce encephalitogenicity of myelin-reactive T cells. J Immunol 1999, 162:35-40
30. Bebo Jr BF, Vandenbark AA, Offner H: Male SJL mice do not relapse after induction of EAE with PLP 139-151. J Neurosci Res 1996, 45:680-689
31. Bebo Jr BF, Zelinka-Vincent E, Adamus G, Amundson D, Vandenbark AA, Offner H: Gonadal hormones influence the immune response to PLP 139-151 and the clinical course of relapsing experimental autoimmune encephalomyelitis. J Neuroimmunol 1998, 84:122-130
32. Smith ME, Eller NL, McFarland HF, Racke MK, Raine CS: Age dependence of clinical and pathological manifestations of autoimmune demyelination. Implications for multiple sclerosis. Am J Pathol 1999, 155:1147-1161
33. Poser S, Raun NE, Poser W: Age at onset, initial symptomatology and the course of multiple sclerosis. Acta Neurol Scand 1982, 66:355-362
34. Liguori M, Marrosu MG, Pugliatti M, Giuliani F, De Robertis F, Cocco E, Zimatore GB, Livrea P, Trojano M: Age at onset in multiple sclerosis. Neurol Sci 2000, 21:3825-3829
35. Sibley WA, Foley JM: Seasonal variation in multiple sclerosis and retrobulbar neuritis in Northeastern Ohio. Trans Am Neurol Assosc 1965, 90:295-297
36. Wuthrich R, Rieder HP: The seasonal incidence of multiple sclerosis in Switzerland. Eur Neurol 1970, 3:257-264
37. Bamford CR, Sibley WA, Thies C: Seasonal variation of multiple sclerosis exacerbations in Arizona. Neurology 1983, 33:697-701
38. Sibley WA, Bramford CR, Clark K: Clinical viral infections and multiple sclerosis. Lancet 1985, 1:1313-1315
39. Goodkin DE, Hertsgaard D: Seasonal variation of multiple sclerosis exacerbations in North Dakota. Arch Neurol 1989, 46:1015-1018
40. Sandyk R, Awerbuch GI: Multiple sclerosis: relationship between seasonal variations of relapse and age of onset. Int J Neurosci 1993, 71:147-157
41. Lymsden CE. The neuropathology of multiple sclerosis. Handbook of Clinical Neurology, vol 9. Edited by PJ Vinken, GW Bruyn. Amsterdam, North-Holland Publishing Co., 1970, pp 217-309
42. Percy AK, Nobrega FT, Kurland LT: Optic neuritis and multiple sclerosis. Arch Ophthalmol 1972, 87:135-139
43. Hutchinson WM: Acute optic neuritis and the prognosis for multiple sclerosis. J. Neurol Neurosurg Psychiatry 1976, 39:283-289
44. Wikstrom J, Poser S, Ritter G: Optic neuritis as an initial symptom in multiple sclerosis. Acta Neurol Scand 1980, 87:135-139
45. Ebers GC: Optic neuritis and multiple sclerosis. Arch Neurol 1985, 42:702-704
46. Francis DA, Compston DAS, Batchelor JR, McDonald WI: A reassessment of the risk of multiple sclerosis developing in patients with optic neuritis after extended follow-up. J Neurol Neurosurg Psychiatry 1987, 50:758-765
47. Rodriguez M, Siva A, Cross SA, O'Brien PC, Kurland LT: Optic neuritis: a population-based study in Olmsted County, Minnesota. Neurology 1995, 45:244-250
48. Cantore WA: Optic neuritis. Pennsylvania Med 1996, 99:S96-S98
49. Soderstrom M, Jin Y-P, Hillert J, Link H: Optic neuritis: prognosis for MS from MRI, CSF and HLA findings. Neurology 1998, 50:708-714
50. Steinman L: Multiple sclerosis: a two stage disease. Nat Immunol 2000, 2:762-764
51. Jin Y-P, de Pedro-Cuesta J, Soderstrom M, Link H: Incidence of optic neuritis in Stockholm, Sweden, 1990-1995. Arch Neurol 1999, 56:975-980
52. Jin Y-P, de Pedro-Cuesta J, Soderstrom M, Stawiarz, Link H: seasonal patterns in optic neuritis and multiple sclerosis: a meta-analysis. J Neurol Sci 2000, 181:56-64
53. Wollnik F: Physiology and regulation of biological rhythms in laboratory animals: an overview. Lab Anim 1989, 23:107-125
54. Gwinner E: Endogenous-exogenous interaction in circannual rhythms. Prog Clin Biol Res 1990, 342:632-638
55. Lincoln GA, Andersson H, Loudon A: Clock genes in calendar cells as the basis of annual timekeeping in mammals - a unifying hypothesis. J Endocr 2003, 179:1-13
56. Oksenberg JR, Barcellos LF, Cree BA, Baranzini SE, Bugawan TL, Khan O, Lincoln RR, Swerdlin A, Mignot E, Lin L, Goodin D, Erlich HA, Schmidt S, Thomson G, Reich DE, Pericak-Vance MA, Haines JL, Hauser SL: Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. Am J Hum Genet 2004, 74:160-167
57. de Jong BA, Huizinga TW, Zanelli E, Giphart MJ, Bollen EL, Uitdehaag BM, Polman CH, Westendorp RG: Evidence for additional genetic risk indicators of relapse-onset MS within the HLA region. Neurology 2002, 59:549-555
58. Palacio LG, Rivera D, Builes JJ, Jimenez ME, Salgar M, Anaya JM, Jimenez I, Camargo M, Arcos-Burgos M, Sanchez JL: Multiple sclerosis in the tropics: genetic association to STR's loci spanning the HLA and TNF. Mult Scler 2002, 8:249-255
59. Shinar Y, Pras E, Siev-Ner I, Gamus D, Brautbar C, Israel S, Achiron A: Analysts of allelic association between D6S461 marker and multiple sclerosis in Ashkenazi and Iraqi Jewish patients. J Mol Neurosci 1998, 11:265-269
60. Fogdell-Hahn A, Ligers A, Gronning M, Hillert J, Olerup O: Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. Tissue Antigens 2000, 55:140-148
61. Marrosu MG, Murru R, Murru MR, Costa G, Zavattari P, Whalen M, Cocco E, Mancosu C, Schirru L, Solla E, Fadda E, Mells C, Porru I, Rolesu M, Cucca F: Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia. Hum Mol Genet 2001, 10:2907-2916
62. Rubio JP, Bahlo M, Butzkueven H, van Der Mei IA, Sale MM, Dickinson JL, Groom P, Johnson LJ, Simmons RD, Tait B, Varney M, Taylor B, Dwyer T, Williamson R, Gough NM, Kilpatrick TJ, Speed TP, Foote SJ: Genetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosis. Am J Hum Genet 2002, 70:1125-1137
63. Lang HL, Jacobsen H, Ikemizu S, Andersson C, Harlos K, Madsen L, Hjorth P, Sondergaard L, Svejgaard A, Wucherpfennig K, Stuart DI, Bell JI, Jones EY, Fugger L: A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat Immunol 2002, 3:940-943
64. Le Movan D, Cogne M, Troutaud D, Charmes JP, Sauvage P, Drouet M: Modification of HLA expression of peripheral lymphocytes and monocytes during aging. Mech Ageing Dev 1998, 105:209-220
65. Le Movan C, Dogne M, Drouet M: HLA-A and HLA-B transcription decrease with ageing in peripheral blood leukocytes. Clin Exp Immunol 2001, 125:245-250
66. Herrero C, Marques L, Lloberas J, Celada A: INF-α-dependent transcription of MHC class II IA is impaired in macrophages from aged mice. J Clin Invest 2001, 107:485-493